共 50 条
Intranasal combo: fixed-dose combination of mometasone furoate and olopatadine hydrochloride in therapeutic strategies for rhinosinusitis
被引:0
|作者:
Samolinski, Boleslaw
[1
]
Wojas, Oksana
[1
]
Lipiec, Agnieszka
[1
]
Krzych-Falta, Edyta
[2
]
Walkiewicz, Artur
[1
]
Borowicz, Jacek
[1
]
Samolinski, Krzysztof
[3
]
机构:
[1] Med Univ Warsaw, Dept Prevent Environm Hazards Allergol & Immunol, Banacha St 1a, PL-02091 Warsaw, Poland
[2] Med Univ Warsaw, Dept Basic Nursing, Warsaw, Poland
[3] Med Univ Warsaw, Dept Emergency Med, Warsaw, Poland
来源:
POLISH JOURNAL OF OTOLARYNGOLOGY
|
2023年
/
77卷
/
06期
关键词:
allergic rhinitis;
ARIA;
EPOS;
mometasone;
olopatadine;
ALLERGIC RHINITIS;
NASAL SPRAY;
AZELASTINE HYDROCHLORIDE;
DELIVERY-SYSTEM;
ASTHMA;
FLUTICASONE;
CHILDREN;
SAFETY;
IMPACT;
CORTICOSTEROIDS;
D O I:
10.5604/01.3001.0054.0941
中图分类号:
R76 [耳鼻咽喉科学];
学科分类号:
100213 ;
摘要:
A novel strategy for the treatment of allergic rhinitis results from the innovative combination of antihistamine and intranasal corticosteroid drugs. By combining two preparations with different mechanism of action, this novel approach facilitates quick and effective controls of all upper respiratory tract allergy symptoms. The article presents the results of a study of olopatadine hydrochloride and mometasone furoate fixed-dose combination (GSP301) administered intranasally from a spray formulation, with an attempt at positioning the treatment within the ARIA and EPOS guidelines.
引用
收藏
页码:43 / 49
页数:7
相关论文